We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

19 hedge funds and large institutions have $7.01M invested in Matinas BioPharma in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 0% → 0.09% (+0.09%)

Holders
19
Holders Change
+19
Holders Change %
–
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJFSA
Raymond James Financial Services Advisors
Florida
+$2.1M
2
AWMG
Alliance Wealth Management Group
New Jersey
+$1.31M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.09M
4
Millennium Management
Millennium Management
New York
+$1M
5
Goldman Sachs
Goldman Sachs
New York
+$723K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
1
Raymond James Financial Services Advisors
Florida
$1.78M +$2.1M +12,861 New
AWMG
2
Alliance Wealth Management Group
New Jersey
$1.16M +$1.31M +8,017 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$925K +$1.09M +6,681 New
Millennium Management
4
Millennium Management
New York
$854K +$1M +6,163 New
Goldman Sachs
5
Goldman Sachs
New York
$614K +$723K +4,434 New
Morgan Stanley
6
Morgan Stanley
New York
$300K +$353K +2,166 New
CDH
7
Charles D. Hyman
$221K +$260K +1,596 New
VKH
8
Virtu KCG Holdings
New York
$193K +$227K +1,390 New
SCM
9
Segantii Capital Management
Hong Kong
$166K +$196K +1,200 New
SIM
10
Spark Investment Management
New York
$105K +$124K +760 New
Creative Planning
11
Creative Planning
Kansas
$103K +$121K +745 New
RJA
12
Raymond James & Associates
Florida
$98K +$116K +709 New
GP
13
GLG Partners
United Kingdom
$97K +$114K +699 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$96K +$113K +693 New
IIA
15
IPG Investment Advisors
California
$95.6K +$113K +690 New
HSBC Holdings
16
HSBC Holdings
United Kingdom
$67K +$79.3K +486 New
BCM
17
BlueCrest Capital Management
Jersey
$66K +$78.3K +480 New
CS
18
Credit Suisse
Switzerland
$58K +$68.7K +421 New
UBS Group
19
UBS Group
Switzerland
$10K +$11.4K +70 New

MTNB Hedge Fund Activity: Q1 2017 in Review

19 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q1 2017, worth a combined $7.01M.

Buyers outnumbered sellers: 19 funds opened new MTNB positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Raymond James Financial Services Advisors, opening a new position worth an estimated $2.1M.

  • 19 institutional investors held Matinas BioPharma (MTNB) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $7.01M of Matinas BioPharma stock for Q1 2017.
  • 19 funds opened new Matinas BioPharma positions in Q1 2017 and 0 closed out, a net change of +19 holders.
  • The largest Matinas BioPharma buyer in Q1 2017 was Raymond James Financial Services Advisors, an estimated $2.1M added.

Based on aggregated 13F filings for Q1 2017.